DE69911614D1 - Komponenten mit niedrigem molekulargewicht aus knorpelgewebe von haien, verfahren zur herstellung und therapeutische verwendungen - Google Patents

Komponenten mit niedrigem molekulargewicht aus knorpelgewebe von haien, verfahren zur herstellung und therapeutische verwendungen

Info

Publication number
DE69911614D1
DE69911614D1 DE69911614T DE69911614T DE69911614D1 DE 69911614 D1 DE69911614 D1 DE 69911614D1 DE 69911614 T DE69911614 T DE 69911614T DE 69911614 T DE69911614 T DE 69911614T DE 69911614 D1 DE69911614 D1 DE 69911614D1
Authority
DE
Germany
Prior art keywords
fraction
mmp
kda
cartilage
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69911614T
Other languages
English (en)
Other versions
DE69911614T2 (de
Inventor
Eric Dupont
Yves Lachance
Denis Lessard
Serge Auger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratories Aeterna Inc
Original Assignee
Les Laboratories Aeterna Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratories Aeterna Inc filed Critical Les Laboratories Aeterna Inc
Publication of DE69911614D1 publication Critical patent/DE69911614D1/de
Application granted granted Critical
Publication of DE69911614T2 publication Critical patent/DE69911614T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69911614T 1998-07-23 1999-07-23 Komponenten mit niedrigem molekulargewicht aus knorpelgewebe von haien, verfahren zur herstellung und therapeutische verwendungen Expired - Fee Related DE69911614T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/122,481 US6168807B1 (en) 1998-07-23 1998-07-23 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
US122481 1998-07-23
PCT/CA1999/000674 WO2000004910A2 (en) 1998-07-23 1999-07-23 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
DE69911614D1 true DE69911614D1 (de) 2003-10-30
DE69911614T2 DE69911614T2 (de) 2004-06-03

Family

ID=22402955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69911614T Expired - Fee Related DE69911614T2 (de) 1998-07-23 1999-07-23 Komponenten mit niedrigem molekulargewicht aus knorpelgewebe von haien, verfahren zur herstellung und therapeutische verwendungen

Country Status (11)

Country Link
US (2) US6168807B1 (de)
EP (1) EP1098656B1 (de)
JP (1) JP2002521340A (de)
CN (1) CN1314816A (de)
AT (1) ATE250422T1 (de)
AU (1) AU4893199A (de)
CA (1) CA2338068A1 (de)
DE (1) DE69911614T2 (de)
ES (1) ES2207248T3 (de)
HK (1) HK1035488A1 (de)
WO (1) WO2000004910A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380366B1 (en) 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
IL131701A (en) 1997-03-11 2005-03-20 Aeterna Zentaris Inc Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
US20020009501A1 (en) * 1998-07-23 2002-01-24 Eric Dupont Preparation of cartilage extracts using organic solvents
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
JP2004516272A (ja) * 2000-12-20 2004-06-03 インダストリアル リサーチ リミテッド サメ肉抽出物
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
WO2003068249A1 (en) * 2002-02-15 2003-08-21 Ocean Nutrition Canada Limited Shark cartilage extracts and use thereof for immunomodulation
CA2509060A1 (en) * 2002-12-27 2004-07-22 Angiotech International Ag Compositions and methods of using collagen and mmpi
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1614697A4 (de) * 2003-03-20 2007-10-10 Hosokawa Micron Kk Aus knorpelfischen isoliertes proteoglykan und herstellungsverfahren dafür
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
US9072735B2 (en) 2005-10-03 2015-07-07 Yong Qian Proteinases destroy cancer tumor's solid structure and kill cancer cells locally
US20080014190A1 (en) * 2005-10-03 2008-01-17 Yong Qian Proteinases destroy cancer tumor's solid structure and kill cancer cells locally
EP2323736A1 (de) * 2008-09-09 2011-05-25 University of East Anglia Behandlung von fibrotischen augenerkrankungen mit einem mmp2-inhibitor
KR101539700B1 (ko) * 2012-09-05 2015-07-28 아주대학교산학협력단 연골세포 유래 세포외 기질막을 이용한 신생혈관질환 치료용 조성물 및 각막 또는 결막 이식재
CN104894200B (zh) * 2015-05-12 2020-10-30 浙江海洋学院 路氏双髻鲨软骨血管生成抑制因子的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28093E (en) 1962-02-28 1974-07-30 Wound-healing cartilage powder
US3478146A (en) 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3966908A (en) 1973-11-29 1976-06-29 Lescarden Ltd. Method of treating degenerative joint afflictions
US4042457A (en) 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4822607A (en) 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4212857A (en) 1976-10-29 1980-07-15 Lescarden Ltd. Method for stimulating the production of immunoglobulin and total complement
US4243582A (en) 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4456589A (en) 1982-07-08 1984-06-26 Genetic Laboratories, Inc. Preparation of animal tissues for surgical implantation in human recipients
US4473551A (en) 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
JPS5939828A (ja) 1982-08-28 1984-03-05 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4444752A (en) 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4469676A (en) 1983-06-21 1984-09-04 Michel Hecmati Method for eliminating wrinkles occurring in the human skin
JPS60178820A (ja) 1984-02-22 1985-09-12 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4656137A (en) 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5075112A (en) 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
US5260205A (en) * 1990-11-14 1993-11-09 Philip Morris Incorporated Method of purifying putrescine N-methyltransferase from tobacco plant extract with a polyamine
EP0571597A4 (en) 1991-11-15 1994-06-01 Arthro Res & Dev Corp Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals
AU5596494A (en) 1992-11-30 1994-06-22 I. William Lane Processing shark cartilage
CA2468375A1 (en) 1993-07-19 1995-02-02 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions, uses and methods
US5618925A (en) 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6025334A (en) 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6028118A (en) 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
RO117590B1 (ro) 1995-02-03 2002-05-30 Aeterna Lab Inc Compozitie pentru tratamentul unei degenerari, boli colagenice sau inflamatorii
US5843920A (en) * 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof

Also Published As

Publication number Publication date
CA2338068A1 (en) 2000-02-03
WO2000004910A3 (en) 2000-05-04
US20010001041A1 (en) 2001-05-10
JP2002521340A (ja) 2002-07-16
ES2207248T3 (es) 2004-05-16
AU4893199A (en) 2000-02-14
CN1314816A (zh) 2001-09-26
ATE250422T1 (de) 2003-10-15
WO2000004910A2 (en) 2000-02-03
US6168807B1 (en) 2001-01-02
DE69911614T2 (de) 2004-06-03
US6506414B2 (en) 2003-01-14
EP1098656B1 (de) 2003-09-24
HK1035488A1 (en) 2001-11-30
EP1098656A2 (de) 2001-05-16

Similar Documents

Publication Publication Date Title
DE69911614D1 (de) Komponenten mit niedrigem molekulargewicht aus knorpelgewebe von haien, verfahren zur herstellung und therapeutische verwendungen
DE69324006D1 (de) Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung
ATE196089T1 (de) Mittel zur hemmung des komplementsystems hergestellt aus fucanen aus braunen algen
ATE119040T1 (de) Zentrale cholecystokinin-antagonisten zur behandlung von psychiatrischen krankheiten.
ATE448323T1 (de) Lösliches hyaluronidase-glycoprotein (shasegp), verfahren zu seiner herstellung, verwendungen und dieses enthaltende pharmazeutische zusammensetzungen
CA2265508A1 (en) Bone morphogenetic protein-16 (bmp-16) compositions
RU2005106873A (ru) Двухфазные композиции на основе полидекстрозы и сахарозы
DE69736391T2 (de) Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines hemmstoffes einer metallabhängigen protease oder chymotrypsins zum zellkulturmedium
ATE247666T1 (de) Wasserlöslische prodrugs von 2,6- diisopropylphenol-analoga
ATE294504T1 (de) Verfahren und zusammensetzungen zur behandlung von zellproliferationsstörungen
SE9804000D0 (sv) New composition of matter
EP2293776B1 (de) Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
GB2334446B (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
DE60034601D1 (de) Verfahren zur herstellung von polyphenolischen adhäsionsproteinen
FR2861731B1 (fr) Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
FR2818903B1 (fr) Composition transparente de traitement cosmetique, de type emulsion eau-dans-huile, et procede de traitement cosmetique des matieres keratiniques
ATE288761T1 (de) Verwendung von glykosaminoglykane zur behandlung seniler demenz
Reichen et al. Binding of unconjugated and conjugated sulfobromophthalein to rat liver plasma membrane fractions in vitro
ATE310020T1 (de) Verfahren zur gewinnung hochgereinigter alginate
DE50107344D1 (de) Herstellung von polygalakturoniden und ihre verwendung als lebensmittelzusatzstoffe
ATE45879T1 (de) Regelverfahren fuer mikroflora und zusammensetzungen dazu.
DK0580829T3 (da) Ekstrakt af bakterielle proteiner, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende den.
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee